Catherine Harlow

Head of Transfer Pricing at ASTRAZENECA

Catherine has 25 years’ experience of advising on transfer pricing matters both in industry and in practice. She has been Head of Transfer Pricing at AstraZeneca since September 2017 where she has global responsibility for all aspects of AstraZeneca’s transfer pricing matters including planning, managing and defending their transfer pricing arrangements. Prior to this, Catherine was Head of Transfer Pricing for the RELX group for 10 years where she managed a multinational team and led negotiations with tax authorities on transfer pricing matters including APAs. Catherine is a Chartered Accountant and Chartered Tax Advisor and has a Masters in Philosophy, Politics and Economics (PPE) from Oxford University.